🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Rocky Mountain Cancer Centers
Start Date
2001-10
Trial ID
NCT00041288
The proposed study is a masked trial, with stratified block randomization b...
Status
Completed
Location
Aravind Eye Hospital
Start Date
2010-10
Trial ID
NCT01232920
Treatments Being Tested
This study will compare the safety and effectiveness of two drugs-methotrex...
Status
Completed
Location
National Institute of Allergy and Infectious Diseases (NIAID)
Start Date
2000-02
Trial ID
NCT00004567
Treatments Being Tested
The purpose of this study is to determine the response and toxicity rate of...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2022-01-01
Trial ID
NCT05166967
Treatments Being Tested
The purpose of the study is to assess the safety and efficacy of haploident...
Status
Unknown
Location
First Affiliated Hospital of Guangxi Medical University
Start Date
2017-04-01
Trial ID
NCT03171831
This randomized clinical trial studies standard GVHD prophylaxis with tacro...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2014-07-07
Trial ID
NCT01951885
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ustekinumab as mea...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-15
Trial ID
NCT02349061
Treatments Being Tested
The objectives of this prospective non-interventional study are to characte...
Status
Recruiting
Location
Cahaba Dermatology & Skin Health Center- Site Number : 8400006
Start Date
2025-11-17
Trial ID
NCT07290803
RATIONALE: Monoclonal antibodies such as gemtuzumab ozogamicin can locate c...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
2000-10
Trial ID
NCT00008151
To assess the efficacy and safety of Abatacept as an immunosuppressive trea...
Status
Completed
Location
UZLeuven
Start Date
2019-04-01
Trial ID
NCT03871361
Treatments Being Tested